Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1989 Nov;27(11):2616–2618. doi: 10.1128/jcm.27.11.2616-2618.1989

Pseudomonas aeruginosa ATCC 49189, a new quality control strain for testing P. aeruginosa susceptibility to the aminoglycosides.

R T Lally 1, B F Woolfrey 1, M A Enright 1
PMCID: PMC267088  PMID: 2509514

Abstract

Quality control for in vitro antimicrobial susceptibility testing of Pseudomonas aeruginosa versus aminoglycosides is improved by P. aeruginosa ATCC 49189, which was developed in the Clinical Microbiology Laboratory at St. Paul-Ramsey Medical Center. This strain, used by us for daily testing for the past 6 years, requires MICs that approximate therapeutic concentrations, are midrange in most dilution schemes, and are stable and reproducible.

Full text

PDF
2616

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barry A. L., Thornsberry C., Jones R. N. Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories. J Clin Microbiol. 1981 May;13(5):1000–1003. doi: 10.1128/jcm.13.5.1000-1003.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barry A. L., Thornsberry C., Jones R. N., Gerlach E. H. Gentamicin, tobramycin, and sisomicin disc susceptibility tests. Revised zone standards for interpretation. Am J Clin Pathol. 1981 Apr;75(4):524–531. doi: 10.1093/ajcp/75.4.524. [DOI] [PubMed] [Google Scholar]
  3. Woolfrey B. F., Fox J. M., Lally R. T., Quall C. O. Broth microdilution testing of Pseudomonas aeruginosa and aminoglycosides: need for employing dilutions differing by small arithmetic increments. J Clin Microbiol. 1982 Oct;16(4):663–667. doi: 10.1128/jcm.16.4.663-667.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Woolfrey B. F., Fox J. M., Quall C. O. Comparison of minimum inhibitory concentration values determined by three antimicrobic dilution methods for Pseudomonas aeruginosa. Am J Clin Pathol. 1981 Jan;75(1):39–44. doi: 10.1093/ajcp/75.1.39. [DOI] [PubMed] [Google Scholar]
  5. Woolfrey B. F., Lally R. T., Ederer M. N., Quall C. O. Evaluation of the automicrobic system for susceptibility testing of Pseudomonas aeruginosa to gentamicin, tobramycin, and amikacin. J Clin Microbiol. 1984 Apr;19(4):502–505. doi: 10.1128/jcm.19.4.502-505.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Woolfrey B. F., Lally R. T., Quall C. O. Comparative evaluation of the micro-media system, sceptor, and MIC-2000 microdilution methods for testing Pseudomonas aeruginosa against gentamicin, tobramycin, and amikacin. J Clin Microbiol. 1983 Feb;17(2):312–316. doi: 10.1128/jcm.17.2.312-316.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES